Background: The significance of circulating tumor DNA (ctDNA) in primary papillary thyroid
cancer (PTC) is yet to be well established. This study aimed to clarify whether ctDNA carrying …

… reported that patients with papillary thyroid carcinoma (PTC) … the frequency of the BRAFV600E
mutation in PTC with and without HT… It was then analyzed for the BRAFV600E mutation by …

… the mechanism of BRAFV600E mutation and … BRAFV600E mutation in preoperative diagnosis
and prognostic stratification, and recent advances in the use of the BRAFV600E mutation …

… , 11 , 12 Previously we demonstrated that papillary thyroid carcinoma with BRAF V600E
mutation was morphologically distinctive. We now investigate the incidence of BRAF V600E …

… We searched for articles which assessed the association between BRAFV600E mutation
and clinicopathological features in patients with PTC. Studies satisfying the following criteria …

… Hashimoto's thyroiditis and BRAF V600E mutation status in patients with papillary thyroid
cancer (PTC) and to determine their combined association with tumor aggressiveness in PTC. …

… Thyroid cancer primarily includes the following four pathological … : papillary thyroid carcinoma,
follicular thyroid carcinoma, undifferentiated carcinoma and medullary thyroid carcinoma. …

… presenting annually (seer.cancer.gov). The most common form of thyroid cancer is papillary
thyroid cancer (PTC), comprising 65–88% of all differentiated thyroid cancers (1). Although …

… status on disease recurrence–free probability in patients with various types of papillary thyroid
cancer (… risk factors in affecting disease-free probability in patients with papillary thyroid …

… –harboring anaplastic thyroid cancer often has a papillary thyroid carcinoma component, …
in promoting the progression of papillary thyroid carcinoma to anaplastic thyroid cancer [17]. …